Nordic venture capital firm Fåhraeus Startup and Growth AB (FSG) has completed the final close of its second fund, FSG Fund II, at €75 million (848 million SEK). The European Investment Fund (EIF) has joined as a key investor, contributing €20 million (233 million SEK), alongside existing backers such as Saminvest. Since launching in 2023, the fund has invested in six startups across the life sciences and technology sectors, including Saga Dx and BrightBid. With the additional capital, FSG aims to expand its portfolio and support early-stage companies in scaling their operations.
Fåhraeus Startup and Growth AB (FSG) specializes in early-stage investments within the life sciences and technology sectors. With a focus on high-growth startups, FSG provides capital and hands-on strategic support to help companies scale. The firm leverages its team’s entrepreneurial and operational expertise to back ventures with strong market potential. Based in Lund, Sweden, FSG plays an active role in fostering innovation across the Nordic region, investing in companies developing transformative solutions in healthcare, AI, and deep tech.
“The EIF’s commitment is a significant endorsement of our mission to support Nordic innovation and drive growth across the Tech and LifeScience sectors” said Linus Wiebe, Managing Director and General Partner of FSG Fund II. “We deeply value the trust placed in us by our investors and remain focused on delivering impactful investments that shape the future of the industry.”
Since its launch in mid-2023, FSG Fund II has made six investments: Saga Dx, Promimic, OssDsign, Din Psykolog, BrightBid and Aplagon. Building on the success of its predecessor, FSG Fund I, which supports 14 companies including Yazen and Oncorena among others, FSG Fund II continues to expand its portfolio of transformative ventures.
“The final close of FSG Fund II marks a pivotal moment for our team and the Nordic venture ecosystem. We are excited to build on our achievements and drive innovation across the region,” Wiebe added.
The EIF’s involvement underscores the strategic importance of Nordic innovation within the European ecosystem. The region has established itself asa hub for cutting-edge advancements in life science and technology, and EIF’s support for FSG Fund II reflects a broader commitment to fostering impactful solutions that address global challenges.
Led by an experienced team of Christer Fåhraeus, Linus Wiebe, Johanna Asklin, Emanuel Stihl, and Alexander Jöndell, FSG Fund II combines extensive entrepreneurial and operational expertise with a hands-on approach to supporting its portfolio companies. The team’s proven track record and commitment to innovation set the foundation for continued success.
Click here to read more VC news.
Read the orginal article: https://arcticstartup.com/fahraeus-startup-growth-e74m-fund/
